Physician profile
Gregory G Char
NPI 1154481216
$3,085.13
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $70.86 · 2021: $154 · 2022: $175 · 2023: $318 · 2024: $2,191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,652 · Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,652.23 |
| Food and Beverage | $857.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,306.79 | 2023-2024 | Dailies Total1, Total30, Precision 1 |
| Sight Sciences, INC. | $317.15 | 2020-2023 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $128.39 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.84 | 2019 | |
| Coopervision INC. | $81.34 | 2023 | Onefit Contact Lens |
| Optovue, INC. | $50.00 | 2019 | |
| Visionix USA, INC | $47.06 | 2022 | |
| Allergan, INC. | $28.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Char listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.